Associations between surgical interventions and mortality and healthcare device use at 3 years of age in infants with trisomy 18: A population-based cohort study in Japan

Saturday, April 29, 2023

12:00 PM – 12:15 PM ET

Location: Convention Center: 146 C

Publication Number: 1315.5

Kana Fukui, National center for child health and development, Okura, Setagaya area,, Tokyo, Japan; Daisuke Shinjo, Tokyo Medical and Dental University, Setagaya, Tokyo, Japan; Yushi Ito, National Center for Child Health and Development, Tokyo, Tokyo, Japan; Shuichi ito, Yokohama City University, Graduate School of Medicine, Yokohama, Kanagawa, Japan; Tetsuya Isayama, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan

Presenting Author(s)

Kana Fukui, MD
neonatologist
National center for child health and development
Okura, Setagaya area,, Tokyo, Japan

Disclosure(s):

Kana Fukui, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Daisuke Shinjo, Ph.D: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Yushi Ito, M.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Shuichi Ito, Ph.D.: Alexion Pharma (Ongoing) (Products/Services: Advisory Committee, Consultant, Speaker Honorarium including speakers bureau, symposia, and expert witness); Asahi kase Pharma (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness); Asahi Kasei Pharma (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Astrazeneca (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Chugai Pharma (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Daiichi Sankyo Pharma (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Japan blood organization (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Kyowa Kirin Pharma (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Maruho Pharma (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Novartis Pharma (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Sanofi (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Takeda Pharmaceutical (Ongoing) (Products/Services: Consultant, Speaker Honorarium including speakers bureau, symposia, and expert witness); Teijin Pharma (Ongoing) (Products/Services: Board Member or Executive Role, Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness); Zenyaku Kogyo (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness)

Testsuya Isayama, MD, MSc, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.